Survivorship

The partnership between The Southern Illinois University School of Medicine and Siteman Cancer Center investigates rural cancer disparities and ways to help educate, train, and implement effective strategies to reduce the disparities seen in rural communities.

Drs. Waters,  Hunleth, and colleagues will used a mixed methods research design to gain in-depth understanding of the psychological and social factors that shape the decision making process that caregivers use to care for their asthmatic children.  This project will provide evidence-based behavioral strategies to improve the lives of 6.2 million children who are affected by asthma.

Ying Liu, MD, PhD, assistant professor of surgery, has received a three-year, research scholar grant from the American Cancer Society to study disparities associated wtih ductal carcinoma in situ (DCIS).

Dr. Yin Cao received a Young Investigator Award from the National Comprehensive Cancer Network. This two-year award will support Dr. Cao in her work addressing colorectal cancer survival disparities among patients diagnosed under age 50 through integrating patients, treatment, and tumor molecular characteristics.

About 11% of colon cancers (CRC) and 18% of rectal cancers occur in adults younger than 50 years. In contrast to the recent population decline in CRC incidence in adults aged 50 and above, CRC incidence has increased in all 5-year age groups between 20 and 49 years. The majority of young-onset CRCs are diagnosed symptomatically with more advanced tumors. Dr. Cao is leading research to discover the genomic landscape of young-onset CRCs and the underlying lifestyle factors that may drive the rising incidence.

This pilot project examined health literacy in the context of kidney cancer and smoking among rural populations in southern and central Illinois.

The MAPP study is a cohort study of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from six sites across the United States. It was designed to better understand the natural history of these conditions and their underlying causes, taking a “whole-body” rather than a bladder- or prostate-specific approach.

This project will develop a preference-sensitive decision support tool for patients considering breast reconstruction after mastectomy. The tool will provide patient education, elicit patients’ preferences, and include personalized risk prediction to aid in the decision making process.

Dr. Yin Cao is leading efforts surround aspirin-based chemoprevention to inform future  multi-level interventions to improve the implementation of precision aspirin primary prevention strategies across systems, providers, and patients.

The PLUS Research Network is a multi-site network designed to develop the evidence base for future clinical trials to prevent the development and progression of lower urinary tract symptoms in women and girls. Current projects include a qualitative focus group study, the development of new instruments to measure bladder health, systematic reviews of the literature, and analyses of existing study data to better understand bladder health and factors that contribute to the development and progression of lower urinary tract symptoms.

The mission of Siteman Cancer Center’s Program for the Elimination of Cancer Disparities (PECaD) is to create a national model for eliminating local and regional disparities in cancer education, prevention and treatment. Through a community advisory committee and community partnerships, PECaD works with community representatives to find solutions that reduce disparities.

The Prostate Cancer Biorepository Network (PCBN) is a Department of Defense (DOD)/ Congressionally Directed Medical Research Program (CDMRP) bioresource that provides tissue and other biospecimens to all prostate cancer investigators.

The PIE study is a cohort study of prostate cancer survivors who underwent prostate surgery at Washington University School of Medicine and Brigham & Women’s Hospital. These men were followed for one year after their surgery to better understand the natural history of treatment side effects, such as urinary incontinence and sexual dysfunction, and possible factors that influence the natural history of these side effects, such as physical activity and obesity.

This project, the Department of Defense Serum Repository Study of the Influence of Infections on Biomarkers of Prostate Pathology, is nested within the large population of men on active U.S. military duty with stored blood samples in the Department of Defense Serum Repository. The project examines the short- and longer-term influence of genitourinary and non-genitourinary infections on biomarkers of prostate pathology to inform the possible influence of infections on later prostate cancer risk.

The goal of this grant from the American Cancer Society is to help cancer patients and survivors choose health insurance plans that best meet their health and financial needs. An existing decision support tool will be tailored based on patient interview data, and the modified tool will be evaluated with a 3-arm randomized trial.

This project will bring evidence-based decision tools to rural communities and attempt to support rural cancer patients’ participation in clinical trials.

The ColoCare Study follows a cohort of men and women who have been newly diagnosed with colorectal cancer (stages I-IV). This project’s main interest is in quality-of-life and in rates of cancer recurrence and death.

Nonadherence can have significant negative health effects for the individual and contribute to increases in hospitalization, healthcare costs, and mortality. Adherence is a complex issue, but cost and affordability of medication is a common and critical barrier.The short-term objective is to identify how patients and healthcare providers approach affordability and adherence and use those data to refine and pilot test an intervention promoting patient-provider discussion about cost, affordability, and adherence. The long- term objective is to deliver interventions to reduce cost-related nonadherence.